In one paragraphArticle in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
19 authors.
Dita MušálkováResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Martin RadinaResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0009-0001-0027-8665 Kendrah KiddResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0003-3771-0949 Hana HartmannováResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0001-7787-832 Helena TrešlováResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Kateřina HodaňováResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Petr VyleťalResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0002-9357-1237 Alena VrbackáResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0003-4640-1646 Miroslav VotrubaResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Antonio SanchezSection on Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.ORCID 0009-0005-9852-0868 Lauren MartinSection on Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.ORCID 0009-0003-6450-5411 Abbigail TaylorSection on Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Alice KimSection on Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Martina ŽivnáResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Anthony J BleyerResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0002-2804-5273 Stanislav KmochResearch Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0002-6239-707 Funding
e-INFRA CZ project 90254European Union MULTIOMICS_CZ (Program Johannes Amos Comenius, ID Project CZ.02.01.01/00/23_020/0008540)NCATS NIH HHS Wake Forest Clinical and Translational Science Award (UL1TR001420)Next Generation EU National Institute for Research of Metabolic and Cardiovascular Diseases (Program EXCELES, ID Project No. LX22NPO5104)NIDDK NIH HHS R21 DK106584NIDDK NIH HHS U01 DK103225The National Center for Medical Genomics LM2023067Univerzita Karlova v Praze UNCE 24/MED/022 and CooperatioU.S. Food and Drug Administration 75F40124C00106
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
CKDmetabolomicstubulointerstitial disease
Identifiers
PMID41746789
PMCPMC12935368
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390